Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Abeona Therapeutics (ABEO) Operating Expenses: 2011-2024

Historic Operating Expenses for Abeona Therapeutics (ABEO) over the last 13 years, with Dec 2024 value amounting to $64.2 million.

  • Abeona Therapeutics' Operating Expenses rose 56.52% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $83.6 million, marking a year-over-year increase of 37.63%. This contributed to the annual value of $64.2 million for FY2024, which is 26.81% up from last year.
  • According to the latest figures from FY2024, Abeona Therapeutics' Operating Expenses is $64.2 million, which was up 26.81% from $50.6 million recorded in FY2023.
  • Abeona Therapeutics' 5-year Operating Expenses high stood at $92.8 million for FY2021, and its period low was $50.6 million during FY2023.
  • Its 3-year average for Operating Expenses is $55.7 million, with a median of $52.3 million in 2022.
  • Its Operating Expenses has fluctuated over the past 5 years, first crashed by 43.63% in 2022, then grew by 26.81% in 2024.
  • Over the past 5 years, Abeona Therapeutics' Operating Expenses (Yearly) stood at $91.4 million in 2020, then climbed by 1.55% to $92.8 million in 2021, then slumped by 43.63% to $52.3 million in 2022, then decreased by 3.24% to $50.6 million in 2023, then grew by 26.81% to $64.2 million in 2024.